×
ADVERTISEMENT

ifosfamide

First Randomized Trial of Treatment Strategies for Ewing Sarcoma Finds OS Differences

High-dose ifosfamide has been identified as a preferred therapy for relapsing-remitting Ewing sarcoma in a phase 3 ...

SEPTEMBER 6, 2022

Neoadjuvant Combo Beneficial in Soft Tissue Sarcoma

In soft tissue sarcomas of the trunk or extremities, a neoadjuvant chemotherapy combination of epirubicin plus ...

MARCH 29, 2017

Neoadjuvant Chemotherapy Yields Benefits in High-Risk STS Patients

Three cycles of full-dose neoadjuvant chemotherapy with epirubicin and ifosfamide improve survival by as much as ...

OCTOBER 14, 2016

Post-op Ifosfamide, Etoposide Adds No Benefit, Increases Harm in Poor Responders

Adding ifosfamide and etoposide to a postoperative regimen including methotrexate, cisplatin and doxorubicin (MAP) ...

SEPTEMBER 15, 2016

Load more